Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward
Tóm tắt
Từ khóa
Tài liệu tham khảo
Carrieri, 1999, Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group, J Epidemiol Community Health, 53, 4, 10.1136/jech.53.1.4
Wood, 2004, Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users, Antivir Ther, 9, 229, 10.1177/135965350400900218
2006
Wolfe, 2007, Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union, Int J Drug Policy, 18, 246, 10.1016/j.drugpo.2007.01.012
Donoghoe, 2007, Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002–2004, Int J Drug Policy, 18, 271, 10.1016/j.drugpo.2007.02.010
Sharma, 2009, A situation update on HIV epidemics among people who inject drugs and national responses in south-east Asia region, AIDS, 23, 1405, 10.1097/QAD.0b013e32832bd7c9
Malta, 2009, Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men, J Acquir Immune Defic Syndr, 52, 629, 10.1097/QAI.0b013e3181b31b8a
Grigoryan, 2009, Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996–2004, PLoS One, 4, e4445, 10.1371/journal.pone.0004445
UN. Political declaration on HIV/AIDS (General Assembly resolution 60/262). United Nations General Assembly Special Session on HIV/AIDS, New York, USA, 2006.
Aceijas, 2006, Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the ‘Treating 3 million by 2005. Making it happen. The WHO strategy’ (‘3by5’), Addiction, 101, 1246, 10.1111/j.1360-0443.2006.01509.x
Wood, 2008, A review of barriers and facilitators of HIV treatment among injection drug users, AIDS, 22, 1247, 10.1097/QAD.0b013e3282fbd1ed
Mathers, 2010, HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, Lancet, 375, 1014, 10.1016/S0140-6736(10)60232-2
2005
Zhang, 2009, Five-year outcomes of the China National Free Antiretroviral Treatment Program, Ann Intern Med, 151, 241, 10.7326/0003-4819-151-4-200908180-00006
Carrieri, 2003, Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users, Int J Behav Med, 10, 1, 10.1207/S15327558IJBM1001_01
Lucas, 2006, Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy, Am J Epidemiol, 163, 412, 10.1093/aje/kwj059
Wood, 2007, Rates of inappropriate antiretroviral prescription among injection drug users, Harm Reduct J, 4, 2, 10.1186/1477-7517-4-2
Altice, 2010, Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs, Lancet, 10.1016/S0140-6736(10)60829-X
Malta, 2008, Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis, AIDS Behav
Kavasery, 2009, Nonstructured treatment interruptions among injection drug users in Baltimore, MD, J Acquir Immune Defic Syndr, 50, 360, 10.1097/QAI.0b013e318198a800
Kerr, 2005, Determinants of HAART discontinuation among injection drug users, AIDS Care, 17, 539, 10.1080/09540120412331319778
Weber, 2009, Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study, HIV Med, 10, 407, 10.1111/j.1468-1293.2009.00701.x
Wood, 2005, Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users, AIDS, 19, 837, 10.1097/01.aids.0000168982.20456.eb
Uhlmann, 2010, Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users, Addiction, 105, 907, 10.1111/j.1360-0443.2010.02905.x
Roux, 2008, The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study, Addiction, 103, 1828, 10.1111/j.1360-0443.2008.02323.x
Roux, 2009, Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment, Clin Infect Dis, 49, 1433, 10.1086/630209
Wang, 2008, Self-reported adherence to antiretroviral treatment among HIV-infected people in Central China, AIDS Patient Care STDS, 22, 71, 10.1089/apc.2007.0047
Altice, 2004, Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication, Clin Infect Dis, 1, S376, 10.1086/421400
Dobkin, 2004, Antiretroviral treatment for multiproblem patients, 60
Bobrik, 2006, The GLOBUS Project: first steps to antiretroviral therapy for injection drug users in Russia
Malta, 2003, Case management of human immunodeficiency virus-infected injection drug users: a case study in Rio de Janeiro, Brazil, Clin Infect Dis, 37, S386, 10.1086/377546
Pradier, 2003, Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study, HIV Clin Trials, 4, 121, 10.1310/BRBV-3941-H1PP-NDRY
Sherer, 2002, HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care, AIDS Care, 14, S31, 10.1080/09540120220149975
Altice, 2003, Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users, J Urban Health, 80, 416, 10.1093/jurban/jtg053
Mamedova E, Lezhentsev K. Effective integration of ARV treatment and substitution treatment in managing patients with AIDS. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; Cape Town, South Africa; July 19, 2009. Abstract MODPED057.
Altice, 2007, Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial, Clin Infect Dis, 45, 770, 10.1086/521166
Lucas, 2004, Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study, Clin Infect Dis, 38, S409, 10.1086/421405
Shin, 2006, Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia, Int J Tuberc Lung Dis, 10, 402
McCance-Katz, 2002, Modified directly observed therapy (MDOT) for injection drug users with HIV disease, Am J Addict, 11, 271, 10.1080/10550490290088072
Conway, 2004, Directly observed therapy for the management of HIV-infected patients in a methadone program, Clin Infect Dis, 38, S402, 10.1086/421404
Seal, 2003, A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users, Drug Alcohol Depend, 71, 127, 10.1016/S0376-8716(03)00074-7
Malotte, 2001, Incentives vs outreach workers for latent tuberculosis treatment in drug users, Am J Prev Med, 20, 103, 10.1016/S0749-3797(00)00283-X
Dhingra, 2008, DOTS in drug addicts with TB: Delhi experience, Indian J Tuberc, 55, 122
Barnett, 2009, Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV, Drug Alcohol Depend, 100, 115, 10.1016/j.drugalcdep.2008.09.017
Barfod, 2006, Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory, BMC Health Serv Res, 6, 154, 10.1186/1472-6963-6-154
Escaffre, 2000, Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs, AIDS Care, 12, 723, 10.1080/09540120020014264
Wood, 2005, Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use, AIDS, 19, 1189, 10.1097/01.aids.0000176219.48484.f1
Werb, 2010, Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis, Lancet Infect Dis, 10, 464, 10.1016/S1473-3099(10)70097-9
Toussova, 2009, Potential bridges of heterosexual HIV transmission from drug users to the general population in St. Petersburg, Russia: is it easy to be a young female?, J Urban Health, 86, 121, 10.1007/s11524-009-9364-5
Kumar, 2008, Women and substance use in India and Bangladesh, Subst Use Misuse, 43, 1062, 10.1080/10826080801918189
Abdala, 2008, Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia, Eur Addict Res, 14, 19, 10.1159/000110407
Castilla, 2005, Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV, J Acquir Immune Defic Syndr, 40, 96, 10.1097/01.qai.0000157389.78374.45
Melo, 2008, Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil, Sex Transm Dis, 35, 912, 10.1097/OLQ.0b013e31817e2491
Granich, 2009, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model, Lancet, 373, 48, 10.1016/S0140-6736(08)61697-9
Wood, 2009, Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study, BMJ, 338, b1649, 10.1136/bmj.b1649
Smit, 2006, Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour, Addiction, 101, 433, 10.1111/j.1360-0443.2006.01339.x
Bouhnik, 2004, Drug injection cessation among HIV-infected injecting drug users, Addict Behav, 29, 1189, 10.1016/j.addbeh.2004.01.006
Long, 2006, Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia, AIDS, 20, 2207, 10.1097/QAD.0b013e328010c7d0
Strathdee, 2010, HIV and risk environment for injecting drug users: the past, present, and future, Lancet, 10.1016/S0140-6736(10)60743-X
Mathers, 2008, Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review, Lancet, 372, 1733, 10.1016/S0140-6736(08)61311-2
Mathers, 2010, Improving the data to strengthen the global response to HIV among people who inject drugs, Int J Drug Policy, 21, 100, 10.1016/j.drugpo.2009.12.007
Chinese Country Coordinating Mechanism. Reducing HIV transmission among and from vulnerable groups and alleviating its impact in seven provinces in China. Proposal to the Global Fund to Fight AIDS, Tuberculosis, and Malaria, 2005.
2006
Archer, 2007
Kamarulzaman, 2009, Antiretroviral therapy in Malaysia: identifying barriers to universal access, HIV Therapy, 3, 573, 10.2217/hiv.09.41
2008
2008
2008
Yuswan F. Scaling up harm reduction services: Malaysia's experience. Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010–2015: confronting HIV among people who inject drugs; Kuala Lumpur, Malaysia; Dec 7, 2009.
Hall, 2006, Illicit opiate abuse, 907
Chisholm, 2006, Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use, Drug Alcohol Rev, 25, 553, 10.1080/09595230600944487
Takenova M. Results of the pilot project on opioid substitution therapy—findings of international expert Sergei Dvoryak on clinical counseling and results on treatment side effects and complications in patients. Bishkek, Kyrgyzstan, 2009 (in Russian).
Basu, 2008, Social costs of robbery and the cost-effectiveness of substance abuse treatment, Health Econ, 17, 927, 10.1002/hec.1305
Ettner, 2006, Benefit-cost in the California treatment outcome project: does substance abuse treatment “pay for itself”?, Health Serv Res, 41, 192, 10.1111/j.1475-6773.2005.00466.x
Warren, 2006, Value for money in drug treatment: economic evaluation of prison methadone, Drug Alcohol Depend, 84, 160, 10.1016/j.drugalcdep.2006.01.010
Tran D, Tran S, Ngyuyen L, et al. Does drug rehabilitation in close settings work in Vietnam? International Harm Reduction Association Conference; April 20–23, 2009; Bangkok, Thailand. Abstr 958.
Malta, 2008, Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review, Addiction, 103, 1242, 10.1111/j.1360-0443.2008.02269.x
Palepu, 2003, Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use, J Acquir Immune Defic Syndr, 32, 522, 10.1097/00126334-200304150-00009
Rhodes, 2005, The social structural production of HIV risk among injecting drug users, Soc Sci Med, 61, 1026, 10.1016/j.socscimed.2004.12.024
Strathdee, 2008, Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico, J Acquir Immune Defic Syndr, 47, 369, 10.1097/QAI.0b013e318160d5ae
Rhodes, 2002, The ‘risk environment’: a framework for understanding and reducing drug-related harm, Int J Drug Policy, 13, 85, 10.1016/S0955-3959(02)00007-5
Tang, 2005, Attitudes, knowledge, and perceptions of Chinese doctors toward drug abuse, J Subst Abuse Treat, 29, 215, 10.1016/j.jsat.2005.06.006
Maron E. Assessment of HIV treatment barriers in 20 Russian cities. St Petersburg, Russia: SIMONA+ (in press).
Elovich, 2008, On drug treatment and social control: Russian narcology's great leap backwards, Harm Reduct J, 5, 23, 10.1186/1477-7517-5-23
2007
Bobrova, 2006, Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities, Drug Alcohol Depend, 82, S57, 10.1016/S0376-8716(06)80010-4
2008
Sabin, 2008, Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study, AIDS Care, 20, 1242, 10.1080/09540120801918651
APN+. Knowledge and access of injecting drug users to HIV, drug dependence and hepatitis C treatment: a five country survey. Bangkok, Thailand: Asian Pacific Network of People living with HIV/AIDS (in press).
Choo M, Paxton S, Kamarulzaman A. Exploring discrimination from HIV-related stigma in Malaysia. IX International Congress on AIDS in Asia and the Pacific; Bali, Indonesia; Aug 12, 2009. Abstr WeOD10-06.
Schleifer, 2006
Kurpita V. Integrating HIV/AIDS treatment and care for IDUs: the Ukrainian experience. Implementer's Meeting; Windhoek, Namibia; June 12, 2009.
Maksymenko, 2010, Criminalisation of injecting drug users in Ukraine: state of affairs, causes, consequences, alternatives, J Soc Commentary, 1
2010
Bobrova, 2007, Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview, Int J Drug Policy, 18, 313, 10.1016/j.drugpo.2007.01.015
2006
Moon, 2008, Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?, AIDS Care, 20, 984, 10.1080/09540120701768446
2008
Shields, 2009
Umar S. Break you down to build you up: the Malaysian experience. 20th Conference on the Reduction of Drug-Related Harm; Bangkok, Thailand; April, 2009. Abstr 510.
Wolfe, 2009
Mazlan, 2006, New challenges and opportunities in managing substance abuse in Malaysia, Drug Alcohol Rev, 25, 473, 10.1080/09595230600883354
Nowak, 2009
Hammett, 2008, ‘Social evils’ and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam, Addiction, 103, 137, 10.1111/j.1360-0443.2007.02053.x
Wolfe, 2010, In rehabilitation's name: ending institutionalised cruelty and degrading treatment of people who use drugs, Int J Drug Policy, 21, 145, 10.1016/j.drugpo.2010.01.008
2010
Kamarulzaman, 2009, Impact of HIV prevention programs on drug users in Malaysia, J Acquir Immune Defic Syndr, 52, S17, 10.1097/QAI.0b013e3181bbc9af
2009
Bezzicheri S. Compulsory drug treatment centres in south and east Asia: rights and effectiveness. 9th International congress on AIDS in Asia and the Pacific; Bali, Indonesia; Aug 10, 2009. Abstr MoOB04-05.
2009
2008
2004
2003
Vychavka, 2010
Kuznetsova A. Prevention and treatment of communicable diseases in prison: what really works? Plenary Room, International Conference 2009: Prison Health Protection; Madrid, Spain; Oct 12, 2009.
Hoang TV. Findings from a longitudinal assessment of care, treatment and support interventions at 2 clinics in HCMC Vietnam. Joint UN Programme on HIV/AIDS Vietnam, Lunchtime Seminar on ART in IDU; Hanoi, Vietnam; Nov 24, 2009.
Wakeman, 2009, Preventing death among the recently incarcerated: an argument for naloxone prescription before release, J Addict Dis, 28, 124, 10.1080/10550880902772423
Coffin, 2008
Green, 2009, Social and structural aspects of the overdose risk environment in St. Petersburg, Russia, Int J Drug Policy, 20, 270, 10.1016/j.drugpo.2008.07.002
Yin, 2007, Nonfatal overdose among heroin users in southwestern China, Am J Drug Alcohol Abuse, 33, 505, 10.1080/00952990701407223
Sergeev, 2003, Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation, J Urban Health, 80, 212, 10.1093/jurban/jtg024
Bergenstrom, 2008, A cross-sectional study on prevalence of non-fatal drug overdose and associated risk characteristics among out-of-treatment injecting drug users in North Vietnam, Subst Use Misuse, 43, 73, 10.1080/10826080701205109
2010
Parfitt, 2006, Vladimir Mendelevich: fighting for drug substitution treatment, Lancet, 368, 279, 10.1016/S0140-6736(06)69060-0
1996
Cherny, 2010, Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative, Ann Oncol, 21, 615, 10.1093/annonc/mdp581
Anderson, 2009
2009
Sharma, 2007, Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment, Int J Drug Policy, 18, 319, 10.1016/j.drugpo.2007.04.001
Davis, 2009, Survey of abuses against injecting drug users in Indonesia, Harm Reduct J, 6, 28, 10.1186/1477-7517-6-28
Thomson, 2010
Needle, 2010
Atun, 2010, The Global Fund's leadership on harm reduction: 2002–2009, Int J Drug Policy, 21, 103, 10.1016/j.drugpo.2010.01.002
Cohen, 1982
Li J. Methadone maintenance treatment development in China. Salzburg Seminar on Effective Drug Treatment; Salzburg, Austria; July 14, 2008.
Orsi, 2010, Call for action to secure universal access to ART in developing countries, Lancet, 375, 1693, 10.1016/S0140-6736(10)60737-4
Krusi, 2010, Social and structural determinants of HAART access and adherence among injection drug users, Int J Drug Policy, 21, 4, 10.1016/j.drugpo.2009.08.003
2008
Mukherjee, 2006, Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence, J Acquir Immune Defic Syndr, 43, S123, 10.1097/01.qai.0000248348.25630.74
Heimer, 2008, Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission, AIDS, 22, 123, 10.1097/QAD.0b013e3282f244ef
Broadhead, 2002, Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study, Soc Sci Med, 55, 235, 10.1016/S0277-9536(01)00167-8
Rawson, 2006, A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals, Addiction, 101, 267, 10.1111/j.1360-0443.2006.01312.x
Ki-moon, 2008
Sidibe M. HIV and drugs: a total strategy. The Bangkok Post (Bangkok), April 20, 2009.
O'Hara M. Curb AIDS and HIV by decriminalising drugs, say experts. The Observer (London), April 19, 2009.
Pillay, 2009